ADC Therapeutics
ADCT
$4.34
Share price
-2.25%
Change (1 day)
123.71%
Change (1 year)
Categories
P/S ratio for ADC Therapeutics (ADCT)
P/S ratio as of April 2024 (TTM): 5.15
According to ADC Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.14935. At the end of 2023 the company had a P/S ratio of 1.92.
P/S ratio history for ADC Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.92 | 35.49% |
| 2022 | 1.42 | -96.89% |
| 2021 | 45.7 | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |